- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07946809
Periodontal Health and Treatment Outcomes in Students From Three Countries
Investigation of the Prevalence, Severity, and Treatment Response of Periodontal Diseases Among Student Groups From Different Countries
This study aims to investigate the prevalence and severity of periodontal diseases among university students from three different national backgrounds (Iranian, Sudanese, and Turkish) and to evaluate their response to periodontal treatment.
A total of 348 students will be included in the study, comprising 116 Iranian, 116 Sudanese, and 116 Turkish students. Periodontal health assessments will be performed, and all participants will receive periodontal treatment according to the study protocol.
The study will compare periodontal disease prevalence and severity among the three groups and evaluate changes in periodontal health following treatment.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
This study investigates the prevalence and severity of periodontal diseases among university students from three different national backgrounds and evaluates their response to periodontal treatment.
A total of 348 university students will be included in the study, consisting of 116 students of Iranian origin, 116 students of Sudanese origin, and 116 students of Turkish origin.
At baseline, all participants will undergo a comprehensive periodontal examination to assess their periodontal health status. Clinical periodontal parameters will be recorded using standardized periodontal assessment methods.
All participants will receive periodontal treatment according to the study protocol. The treatment includes professional scaling and oral hygiene instruction. Root planing will be performed when clinically indicated, depending on the periodontal condition of each participant.
Three weeks after treatment, participants will undergo a follow-up periodontal examination. Clinical periodontal parameters will be reassessed to evaluate changes in periodontal health and treatment response.
The findings will be compared among the three student groups to investigate differences in periodontal disease prevalence, severity, and response to treatment.
The study aims to provide information about periodontal health differences among students from different national backgrounds and their response to periodontal treatment.
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Esra İlkerli Şençağlı, Dt.
- Telefonnummer: +905338408701
- E-post: esra.ilkerli@kstu.edu.tr
Studieorter
-
-
-
Mórfou, Cypern
- Rekrytering
- Cyprus Health and Social Sciences University
-
Kontakt:
- Esra İlkerli Şençağlı
- Telefonnummer: +905338408701
- E-post: esra.ilkerli@kstu.edu.tr
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Being 18 years of age or older.
- Having been born and raised in a country different from the country of current study.
- Currently being enrolled as a student at Cyprus Health and Social Sciences University.
- Having received no periodontal treatment within the previous six months.
- Having at least 20 natural teeth.
- Voluntarily agreeing to participate in the study and providing written informed consent.
Exclusion Criteria:
- Completely edentulous individuals.
- Individuals who have used systemic antibiotics or anti-inflammatory medications within the previous six months.
- Individuals with a history of periodontal surgery.
- Pregnant or breastfeeding individuals.
- Individuals with immunosuppression due to systemic diseases or medical conditions (e.g., chemotherapy or HIV).
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Periodontal Treatment Group
All 348 participants will receive periodontal treatment according to their individual clinical needs. Treatment will include scaling and root planing when clinically indicated. Participants will be evaluated at baseline and reassessed three weeks after treatment to assess periodontal treatment outcomes. |
Participants will receive non-surgical periodontal treatment according to their individual clinical needs. The treatment will include scaling and root planing where clinically indicated. The procedure will be performed based on baseline periodontal examination findings. All participants will be reassessed three weeks after treatment to evaluate changes in periodontal clinical parameters, including plaque index, gingival index, probing pocket depth, clinical attachment level, and tooth mobility. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in Probing Pocket Depth (PPD)
Tidsram: Baseline and 3 weeks after periodontal treatment
|
Change in mean probing pocket depth (PPD) from baseline to the three-week follow-up after periodontal treatment. Measurements will be compared among Iranian, Sudanese, and Turkish student groups. |
Baseline and 3 weeks after periodontal treatment
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in Plaque Index (PI) Assessed Using the Silness and Löe Plaque Index
Tidsram: Baseline and 3 weeks
|
Dental plaque will be assessed clinically using the Silness and Löe Plaque Index (1964). Plaque accumulation will be scored on a scale ranging from 0 to 3: 0: No plaque.
The minimum score is 0 and the maximum score is 3. Higher scores indicate greater plaque accumulation and a worse oral hygiene outcome. Measurements will be performed at baseline and 3 weeks after periodontal treatment. |
Baseline and 3 weeks
|
|
Change in Gingival Index (GI) Assessed Using the Löe and Silness Gingival Index
Tidsram: Baseline and 3 weeks
|
Gingival inflammation will be assessed clinically using the Löe and Silness Gingival Index (1963). Gingival tissues will be scored on a scale ranging from 0 to 3: 0: Normal gingiva, no inflammation.
The minimum score is 0 and the maximum score is 3. Higher scores indicate more severe gingival inflammation and a worse periodontal outcome. Measurements will be performed at baseline and 3 weeks after periodontal treatment. |
Baseline and 3 weeks
|
|
Change in Clinical Attachment Level (CAL)
Tidsram: Baseline and 3 weeks
|
Baseline and 3 weeks
|
|
|
Change in Tooth Mobility Assessed Using the Miller Mobility Index
Tidsram: Baseline and 3 weeks
|
Tooth mobility will be assessed clinically using the Miller Mobility Index. Each examined tooth will be evaluated for horizontal and vertical mobility using two rigid instrument handles. Mobility will be classified as follows: Grade 0: Physiologic tooth mobility. Grade 1: Slight horizontal mobility of less than 1 mm. Grade 2: Horizontal mobility of more than 1 mm without vertical mobility. Grade 3: Severe horizontal mobility accompanied by vertical mobility. Higher grades indicate greater tooth mobility and a worse periodontal outcome. Tooth mobility will be assessed at baseline and 3 weeks after periodontal treatment. |
Baseline and 3 weeks
|
|
Change in Bleeding on Probing (BOP) Percentage
Tidsram: Baseline and 3 weeks
|
Bleeding on probing (BOP) will be assessed as a clinical indicator of gingival inflammation using a periodontal probe. The periodontal probe will be gently inserted into the gingival sulcus to evaluate the presence or absence of bleeding following probing. Each periodontal site will be recorded using a dichotomous scoring system: Score 0: Absence of bleeding on probing. Score 1: Presence of bleeding on probing. The BOP percentage will be calculated by dividing the total number of bleeding-positive sites by the total number of examined periodontal sites and multiplying by 100. BOP (%) = (Number of bleeding-positive sites / Total number of examined sites) × 100. The minimum value is 0% and the maximum value is 100%. Higher percentages indicate a greater proportion of bleeding sites and more pronounced gingival inflammation. |
Baseline and 3 weeks
|
|
Prevalence and Severity of Periodontal Disease
Tidsram: Baseline
|
Baseline
|
Samarbetspartners och utredare
Sponsor
Utredare
- Studiestol: Halil İbrahim Taşer, Prof.Dr., Cyprus Health and Social Sciences University
- Huvudutredare: Esra İlkerli Şençağlı, Dt., Cyprus Health and Social Sciences University
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- ESRA-PERIO-001
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .